This article outlines a two-step diagnostic process for Cushing syndrome. The first step uses dexamethasone suppression tests and cortisol measurements to confirm the diagnosis. The second step identifies the syndrome’s cause using ACTH assays and adrenal imaging. The proposed method aims to improve diagnostic accuracy and reduce unnecessary tests. The authors emphasize the importance of following a structured diagnostic pathway.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Diagnosing Cushing syndrome remains a complex clinical challenge due to overlapping symptoms with other endocrine conditions. Prior research has shown that elevated cortisol levels alone are insufficient for diagnosis. No prior work had resolved the most effective sequence of tests to confirm and classify the syndrome. This gap motivated the search for a standardized diagnostic approach. Establishing a clear diagnostic pathway could improve patient outcomes. The need for a two-step diagnostic strategy was evident in clinical practice. Existing methods lacked specificity for determining the syndrome’s cause. A structured diagnostic process could reduce unnecessary imaging and invasive procedures.
Purpose Of The Study:
The aim of this work is to evaluate current diagnostic methods for Cushing syndrome and propose a streamlined approach. The specific problem addressed is the lack of consensus on optimal testing sequences. The motivation stems from the need for a reliable diagnostic framework. Current methods may lead to diagnostic delays or misclassification. This paper seeks to clarify the most effective tests for initial diagnosis. It also aims to identify the most useful tools for determining the syndrome’s etiology. The proposed strategy aims to reduce diagnostic uncertainty. The study focuses on improving diagnostic accuracy and efficiency.
The authors propose a two-step diagnostic process. The first step involves dexamethasone suppression tests and cortisol measurements.
Absence of overnight cortisol suppression by dexamethasone and elevated urinary free cortisol and midnight cortisol levels confirm the diagnosis.
The high-dose dexamethasone test helps distinguish between pituitary and ectopic sources of cortisol overproduction.
Iodocholesterol scintigraphy provides functional imaging of the adrenal glands to identify the syndrome’s cause.
Main Methods:
The study reviews existing diagnostic techniques for Cushing syndrome. It evaluates the use of overnight dexamethasone suppression tests. Urinary free cortisol levels are considered as a diagnostic marker. Midnight plasma cortisol measurements are also included in the analysis. The authors assess the role of baseline plasma ACTH assays in classification. High-dose dexamethasone tests are examined for differential diagnosis. Iodocholesterol scintigraphy is considered for adrenal visualization. Computed tomography is also evaluated for adrenal imaging.
Main Results:
The absence of overnight cortisol suppression by dexamethasone is a key finding. Elevated urinary free cortisol and midnight cortisol levels confirm the diagnosis. These tests are sufficient for most patients with Cushing syndrome. The next diagnostic step involves determining the syndrome’s cause. Baseline plasma ACTH levels help distinguish between subtypes. High-dose dexamethasone tests differentiate pituitary from ectopic sources. Iodocholesterol scintigraphy provides functional adrenal imaging. Computed tomography offers anatomical adrenal assessment.
Conclusions:
The authors propose a two-step diagnostic strategy for Cushing syndrome. The first step combines dexamethasone suppression tests and cortisol measurements. These tests establish the diagnosis in most cases. The second step identifies the syndrome’s cause through ACTH and imaging. The proposed method reduces the need for multiple diagnostic procedures. It streamlines the diagnostic process for clinical use. The findings suggest that this approach improves diagnostic accuracy. The authors emphasize the importance of following this structured pathway.
Midnight cortisol levels are elevated in Cushing syndrome and help confirm the diagnosis when combined with other tests.
Baseline ACTH levels help differentiate between Cushing disease and other subtypes of Cushing syndrome.